No insider purchase over the last 90 days. The latest, by Wiley Matthew T., was filed 06 Mar 2019.
Foamix Pharmaceuticals Ltd. is a listed company. Its insiders report their share dealings to SEC (Form 4). Foamix Pharmaceuticals Ltd. has had no insider filing for more than a year; the last one goes back to 18 March 2020.
Over the whole record (from 2018), the tally stands at 4 purchases and 40 sales.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2019 · cache
25 of 126 declarations
Foamix Pharmaceuticals Ltd. is a biopharmaceutical company focused on developing topical treatments for skin diseases. It aims to provide innovative solutions to enhance patients' quality of life.